Completed PHASE4 INTERVENTIONAL 2-arm NCT00125736

A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium

Sponsor: Eisai Co., Ltd.

Interventions E0671 E0671 placebo rabeprazole sodium

Updated 7 times since 2017 Last updated: Oct 26, 2018 Started: Aug 1, 2005 Primary completion: Apr 19, 2007 Completion: Apr 19, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Stomach Ulcer and is currently completed. Eisai Co., Ltd. leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Nov 2018 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eisai Co., Ltd.

Data source: Eisai Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akita, Japan , Asahikawa, Japan , Chikushino-shi, Japan , Fukoka, Japan , Gifu, Japan , Hamamatsu, Japan , Hashima, Japan , Hasuda, Japan , Hiroshima, Japan , Ikeda, Japan and 33 more locations